Cardiac Analysers Support Rapid Diagnosis of Cardiovascular Disease at CUH Addenbrooke’s

Laboratory products

Cardiac Analysers Support Rapid Diagnosis of Cardiovascular Disease at CUH Addenbrooke’s

08 Sep, 2015

Published over 10 years ago. See the latest and most current information on Laboratory products.

Addenbrooke’s Hospital’s Emergency Department (ED), part of Cambridge University Hospitals NHS Foundation Trust, has become the first UK site to install two Stratus® CS 200 Acute Care Diagnostic cardiac analysers. The technology from Siemens Healthcare Diagnostics is enabling rapid diagnosis of cardiovascular disease (CVD) to quickly determine an appropriate treatment plan.

The Acute Care Diagnostic analysers are supporting the Trust to meet the NHS maximum four-hour wait A&E guidelines. Previously, when samples were sent to the Central Laboratory, it could take up to three hours from test to reporting results. With the new systems in place, the department can undertake testing in the Emergency Department and rapidly gain results in approximately 14 minutes, therefore taking around 35 minutes for the whole cycle from testing to the delivery of results.

The Stratus CS200 analyser features a touchscreen interface, enabling easy navigation of menus as well as a barcode reader to eliminate the need for manual entry. The system also allows results to be reported in dual units, for easy interpretation by clinicians. It delivers a robust cardiac assay menu, including guideline acceptable sensitive Troponin I, meeting European Society of Cardiology and American College of Cardiology Joint Committee recommendations of ≤10% CV at the 99th percentile of normal population.

Other assays include D-Dimer, an important test performed in patients with suspected thrombotic disorders and βhCG which is used as an early pregnancy detection marker, to guide diagnostic testing decisions. CardioPhase® hsCRP is available for assessing risk of future cardiovascular disease and NT-proBNP which aids in diagnosis and assessment of severity of congestive heart failure and used for risk stratification of patients with acute coronary syndrome and heart failure. Myoglobin is available for patients in need of early diagnosis of myocardial infarction and CKMB Mass as an alternative to Troponin I.

Afia Boamah, POC Product Manager at Siemens Healthcare Diagnostics comments, “Siemens has a strong relationship with Addenbrooke’s Hospital and was delighted to pilot the new Stratus CS200 systems in the Emergency Department to advance the site’s point-of-care offering. We worked closely with the team and responded to feedback to ensure the technology met their needs, in turn improving patient pathways and outcomes.”

Latest News

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Mobile platform for real-time water quality monitoring, calibration and data management
Explore more Arrow
Pollution Solutions Online
DNV introduces new framework for measuring onboard carbon capture performance
Explore more Arrow
Petro Online
New test method ASTM D8606 has been officially released
Explore more Arrow
Chromatography Today
Affordable liquid chromatography solvent delivery pump
Explore more Arrow